Výsledky vyhledávání

Akademický článek

Anti-TNF therapy for inflammatory bowel disease in patients with neurodegenerative Niemann-Pick disease Type C.

Autor: Williams I; Translational Gastroenterology Unit, University of Oxford, Oxford, UK., Pandey S; Translational Gastroenterology Unit, University of Oxford, Oxford, UK., Haller W; Birmingham Children's Hospital, UK, Birmingham, UK., Huynh HQ; Department of Paediatrics, Stollery Children's Hospital, University of Alberta, Alberta, Canada., Chan A; Division of Clinical Genetics, Stollery Children's Hospital, University of Alberta, Alberta, Canada., Düeker G; University Children's Hospital Bonn, Bonn, Germany., Bettels R; Children's Hospital Munster, Munster, Germany., Peyrin-Biroulet L; Inserm U1256 NGERE, 8 Lorraine University, Vandoeuvre-les-Nancy, France.; Department of Gastroenterology, Nancy University Hospital Center, Vandoeuvre-les-Nancy, France., Dike CR; Stead Family Department of Pediatrics, University of Iowa, Iowa, USA., DeGeeter C; Stead Family Department of Pediatrics, University of Iowa, Iowa, USA., Smith D; Department of Pharmacology, University of Oxford, Oxford, UK., Al Eisa N; Department of Pharmacology, University of Oxford, Oxford, UK.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Platt N; Department of Pharmacology, University of Oxford, Oxford, UK., Marquardt T; Children's Hospital Munster, Munster, Germany., Schwerd T; Department of Paediatrics, Dr. von Hauner Children's Hospital, Munich, Germany., Platt FM; Department of Pharmacology, University of Oxford, Oxford, UK., Uhlig HH; Translational Gastroenterology Unit, University of Oxford, Oxford, UK.; Department of Paediatrics, University of Oxford, Oxford, UK.; Biomedical research centre, University of Oxford, Oxford, UK.

Publikováno v: Wellcome open research [Wellcome Open Res] 2022 Jan 11; Vol. 7, pp. 11. Date of Electronic Publication: 2022 Jan 11 (Print Publication: 2022).

Zobrazit plný text záznamu

Akademický článek

Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway.

Autor: Fineran P; Department of Pharmacology, University of Oxford, Oxford, UK., Lloyd-Evans E; Department of Pharmacology, University of Oxford, Oxford, UK.; School of Biosciences, Cardiff University, Cardiff, UK., Lack NA; Department of Pharmacology, University of Oxford, Oxford, UK.; School of Medicine, Koç University, Istanbul, Turkey., Platt N; Department of Pharmacology, University of Oxford, Oxford, UK., Davis LC; Department of Pharmacology, University of Oxford, Oxford, UK., Morgan AJ; Department of Pharmacology, University of Oxford, Oxford, UK., Höglinger D; Department of Pharmacology, University of Oxford, Oxford, UK., Tatituri RVV; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA., Clark S; Public Health England, Salisbury, UK., Williams IM; Department of Pharmacology, University of Oxford, Oxford, UK., Tynan P; Department of Pharmacology, University of Oxford, Oxford, UK., Al Eisa N; Department of Pharmacology, University of Oxford, Oxford, UK., Nazarova E; Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, USA., Williams A; Public Health England, Salisbury, UK., Galione A; Department of Pharmacology, University of Oxford, Oxford, UK., Ory DS; Diabetic Cardiovascular Disease Center, Washington University School of Medicine, St. Louis, USA., Besra GS; School of Biosciences, University of Birmingham, Birmingham, UK., Russell DG; Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, USA., Brenner MB; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA., Sim E; Department of Pharmacology, University of Oxford, Oxford, UK.; Faculty of Science Engineering and Computing, Kingston University, Kingston upon Thames, UK., Platt FM; Department of Pharmacology, University of Oxford, Oxford, UK.

Publikováno v: Wellcome open research [Wellcome Open Res] 2016 Nov 18; Vol. 1, pp. 18. Date of Electronic Publication: 2016 Nov 18.

Zobrazit plný text záznamu

Akademický článek

Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease.

Autor: Nicoli ER; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Al Eisa N; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Cluzeau CV; Section of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America., Wassif CA; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.; Section of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America., Gray J; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Burkert KR; Section of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America., Smith DA; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Morris L; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Cologna SM; Section of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America., Peer CJ; Clinical Pharmacology Program, Medical Oncology Branch, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland, United States of America., Sissung TM; Clinical Pharmacology Program, Medical Oncology Branch, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland, United States of America., Uscatu CD; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.; Department of Cellular and Molecular Biology, University of Medicine and Pharmacy of Craiova, Craiova, Romania., Figg WD; Clinical Pharmacology Program, Medical Oncology Branch, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland, United States of America., Pavan WJ; Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America., Vite CH; School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America., Porter FD; Section of Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America., Platt FM; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.

Publikováno v: PloS one [PLoS One] 2016 Mar 28; Vol. 11 (3), pp. e0152007. Date of Electronic Publication: 2016 Mar 28 (Print Publication: 2016).

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání